➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts

Last Updated: June 22, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for DDP-225

Email this page to a colleague

« Back to Dashboard

What is the drug development status for DDP-225?

DDP-225 is an investigational drug.

There have been 35 clinical trials for DDP-225. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2011.

The most common disease conditions in clinical trials are Carcinoma, Nasopharyngeal Neoplasms, and Esophageal Neoplasms. The leading clinical trial sponsors are Sun Yat-sen University, Fudan University, and Peking University.

Recent Clinical Trials for DDP-225
Nab-paclitaxel Based TPX Neoadjuvant Chemotherapy for NPC Patients: a Dose-escalation StudySun Yat-sen UniversityPhase 1
Drugs Brain and Behavior (DDP)University of ChicagoEarly Phase 1
Efficacy and Safety of ddEC-ddP for Neoadjuvant Chemotherapy of HER2-negative Breast CancerSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 2/Phase 3

See all DDP-225 clinical trials

Clinical Trial Summary for DDP-225

Top disease conditions for DDP-225
Top clinical trial sponsors for DDP-225

See all DDP-225 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.